DENTSPLY SIRONA (NASDAQ:XRAY) Upgraded by Bank of America to “Buy” Rating

Bank of America upgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY) from a neutral rating to a buy rating in a research report sent to investors on Thursday, Marketbeat reports. Bank of America currently has $17.00 price target on the medical instruments supplier’s stock, up from their prior price target of $13.00.

Several other brokerages also recently weighed in on XRAY. Wells Fargo & Company cut their price target on DENTSPLY SIRONA from $15.00 to $12.00 and set an “equal weight” rating on the stock in a report on Friday, November 7th. Barrington Research restated an “outperform” rating and set a $14.00 target price on shares of DENTSPLY SIRONA in a research note on Monday, January 5th. Weiss Ratings reiterated a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research note on Wednesday, January 21st. Mizuho boosted their price target on shares of DENTSPLY SIRONA from $13.00 to $14.00 and gave the stock a “neutral” rating in a report on Tuesday, January 20th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a report on Friday, November 7th. Three analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $14.46.

DENTSPLY SIRONA Stock Up 0.2%

Shares of XRAY opened at $12.52 on Thursday. The company’s 50-day simple moving average is $12.21 and its 200-day simple moving average is $12.50. The company has a debt-to-equity ratio of 1.36, a quick ratio of 0.99 and a current ratio of 1.47. DENTSPLY SIRONA has a 1 year low of $9.85 and a 1 year high of $19.27. The stock has a market capitalization of $2.50 billion, a PE ratio of -2.83, a P/E/G ratio of 0.98 and a beta of 1.01.

DENTSPLY SIRONA Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, January 9th. Investors of record on Friday, December 26th were given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 5.1%. The ex-dividend date of this dividend was Friday, December 26th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -14.48%.

Insider Buying and Selling

In related news, Director Gregory T. Lucier sold 82,200 shares of the business’s stock in a transaction on Monday, December 8th. The shares were sold at an average price of $11.14, for a total value of $915,708.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.50% of the stock is owned by corporate insiders.

Institutional Trading of DENTSPLY SIRONA

Institutional investors and hedge funds have recently made changes to their positions in the company. Compound Planning Inc. purchased a new position in DENTSPLY SIRONA during the 4th quarter worth approximately $117,000. Invesco Ltd. grew its position in shares of DENTSPLY SIRONA by 101.1% during the fourth quarter. Invesco Ltd. now owns 1,063,523 shares of the medical instruments supplier’s stock worth $12,156,000 after acquiring an additional 534,714 shares during the last quarter. Michels Family Financial LLC increased its holdings in shares of DENTSPLY SIRONA by 8.9% in the 4th quarter. Michels Family Financial LLC now owns 41,989 shares of the medical instruments supplier’s stock valued at $480,000 after acquiring an additional 3,422 shares during the period. Alpine Woods Capital Investors LLC purchased a new stake in DENTSPLY SIRONA in the 4th quarter valued at $680,000. Finally, First Citizens Bank & Trust Co. acquired a new stake in DENTSPLY SIRONA during the 4th quarter worth $447,000. 95.70% of the stock is owned by hedge funds and other institutional investors.

About DENTSPLY SIRONA

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.